| Catalyst | Drug/Treatment | Stage | Probability of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Example Drug Treatment for example condition requiring FDA review | Phase 3 | -% | Small Molecule | Oncology | ||
PDUFA 2026 | Example Drug Treatment for example condition requiring FDA review | Phase 3 | -% | Small Molecule | Oncology | ||
PDUFA 2026 | Example Drug Treatment for example condition requiring FDA review | Phase 3 | -% | Small Molecule | Oncology |
Recent Updates
Recently added Catalysts
OmniAb, Inc. Common Stock$2.39
-0.1 (-3.83%)
Market Cap
212.83 M
EPS
-0.58
P/E Ratio
-2.55 $
Value Trade
1.03 M
SEC Financials
Q1 2026Dilution Risk
Revenue
14.43 M
R&D Expenses
9.64 M
Operating CF
-4.91 M
Total Assets
293.65 M
Total Liabilities
31.00 M
Equity
262.65 M
%
Week
%
1 Month
%
3 Month
%
6 Month
%
5 Year
%
All Time
Cash Data
Cash Position
49.07 M
Monthly Burn
1.64 M
Runway
29.1 mo
Burn Trend
SEC Filing
May 7, 2026
Overview
Volume
276.24 K
52 Week Range
1.22 - 2.30
% held by Insiders
18.56 %
% held by Institutions
47.2 %
Enterprise Value
179.14 M
Total Shares
144.07 M
Short %
4.17 %
Float Shares
73.91 M
Company Description
OmniAb Inc licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation therapeutics. Its technology platform cre Read More+
Upcoming Catalyst
Drug Pipeline Intelligence
OABI Clinical Trial Results & History
| Drug Name | Indications | Phase | Date | Trial Results Summary | Title | Source |
|---|---|---|---|---|---|---|
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | |||
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | |||
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 |
Inside Trades
YEARLY INSIDER TRANSACTIONS
Sector Avg.
INSIDERS
SOLDINSIDERS
BOUGHT
SOLDINSIDERS
BOUGHT
POSITIVE SENTIMENT Based on 22 Insiders Transactions
Hedge Funds
Shares Held
HEDGE FUNDS
SOLDHEDGE FUNDS
BOUGHT
SOLDHEDGE FUNDS
BOUGHT
POSITIVE SENTIMENT Based on 27 hedge funds in the last quarter
18 buying (3 new)·9 selling (1 exited)·2 unchanged
Hedge Funds invested in OABI
| HedgeFund Name ( 3 ) | % of Portfolio | Current MV 1.30 M (-66.84%) | Shares Owned 701.00 K (-71.3%) | Activity Avg Price $0 |
|---|---|---|---|---|
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K |
OmniAb, Inc. Common Stock (OABI) Analyst Ratings & Price Targets
Symbol
Firm
Rating
Action
Price Target
Upside
date
OABI
Example Securities
Buy
Initiated
$150.00
+25%
2026-01-15
OABI
Example Securities
Buy
Initiated
$150.00
+25%
2026-01-15
OABI
Example Securities
Buy
Initiated
$150.00
+25%
2026-01-15
OABI Stock Forecast & Analyst Consensus
BUY
Analyst Ratings
Buy65.0%
Hold25.0%
Sell10.0%
Price Target Trend
Average$24.00
Low$18.00
High$32.00
OABI Institutional Ownership Trends
Current Insider %
5.20%
—+0.00%
Current Institutional %
62.40%
—+0.00%
Total Ownership
67.60%
Insider + Institutional
Data Points
1
1 Ticker(s)
OABI Option Chain Statistics
| Expiration | Volume | Open Interest | Implied Volatility Calls | Implied Volatility Puts | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Calls | Puts | Put-Call Ratio | Calls | Puts | Put-Call Ratio | IV | OiWaIv | VWaIv | IV | OiWaIv | VWaIv | |
| 2026-06-18 | 4 | 1 | 4.00 | 60 | 1 | 0.02 | 5.84% | 3.47% | 2.38% | 2.57% | 2.57% | 2.57% |
| 2026-06-18 | 4 | 1 | 4.00 | 60 | 1 | 0.02 | 5.84% | 3.47% | 2.38% | 2.57% | 2.57% | 2.57% |
| 2026-06-18 | 4 | 1 | 4.00 | 60 | 1 | 0.02 | 5.84% | 3.47% | 2.38% | 2.57% | 2.57% | 2.57% |
Real-Time OABI Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last Price | Volume | Open Interest | Last Price | Volume | Open Interest | |
| 0.25 | 3 | 15 | 2.5 | 0.21 | 1 | 1 |
| 0.25 | 3 | 15 | 2.5 | 0.21 | 1 | 1 |
| 0.25 | 3 | 15 | 2.5 | 0.21 | 1 | 1 |
Open interest
Today's Open Interest
1.00 M
Put-Call Ratio
1.1
Put Open Interest
480.00 K
Call Open Interest
520.00 K
Open Interest Avg (30-day)
900,000
Today vs Open Interest Avg (30-day)
11.11%
OABI Option Volume & Put-Call Ratio
Today's Volume
750.00 K
Put-Call Ratio
0.95
Put Volume
360.00 K
Call Volume
390.00 K
Volume Avg (30-day)
800,000
Today vs Volume Avg (30-day)
-6.25%
Latest OmniAb, Inc. Common Stock (OABI) News & Alerts
-
Demo Biotech Announces Positive Phase 3 Results
Competitive Position
How OABI ranks across every disease it competes in No competitive intelligence available for OABI.